Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome

INTRODUCTION: Many medicines have adverse effects which are difficult to detect and frequently go unrecognised. Pharmacist monitoring of changes in signs and symptoms of these adverse effects, which we describe as medicine-induced deterioration, may reduce the risk of developing frailty. The aim of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Open
Главные авторы: Lim, Renly, Bereznicki, Luke, Corlis, Megan, Kalisch Ellett, Lisa M, Kang, Ai Choo, Merlin, Tracy, Parfitt, Gaynor, Pratt, Nicole L, Rowett, Debra, Torode, Stacey, Whitehouse, Joseph, Andrade, Andre Q, Bilton, Rebecca, Cousins, Justin, Kelly, Lan, Schubert, Camille, Williams, Mackenzie, Roughead, Elizabeth Ellen
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Geriatric Medicine
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204916/
https://ncbi.nlm.nih.gov/pubmed/32327474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-032851
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы